CAS: 3438-16-2; 5-Chloro-2-Methoxybenzoic Acid

上下游产品

CAS号33924-48-0 5-氯-2-甲氧基苯甲酸甲酯 | CAS号321-14-2 5-氯代水杨酸 | CAS号74-88-4 碘甲烷 | CAS号623-12-1 4-氯苯甲醚 | CAS号60633-25-2 2-溴-4-氯苯甲醚 | CAS号63213-94-5 4-(5-氯-2-甲氧基-苯基... | CAS号6342-64-9 5-氯-2-甲氧基苯乙酮 | CAS号1450-74-4 2-羟基-5-氯苯乙酮 | CAS号77-78-1 硫酸二甲酯 | CAS号3260-85-3 5-氯-2-甲氧基甲苯 | CAS号321-14-2 5-氯代水杨酸 | CAS号19165-63-0 °Chratoxin α | CAS号25921-64-6 5-chloro-2-meth... | CAS号29568-33-0 5-氯-2-甲氧基苯甲酰氯 | CAS号32060-31-4 5-chloro-N-(2-c... | CAS号349434-79-3 5-Chloro-2-meth... | CAS号623-12-1 4-氯苯甲醚 | CAS号7035-11-2 4-氯-2-氯甲基-1-甲氧基苯 | CAS号54870-28-9 Meglitinide | CAS号41433-12-9 2-(1H-苯并[d]咪唑-2...

4-(5-氯-2-甲氧基-苯基)-4-氧代-丁酸置于氢氧化钾,Potassium Permanganate体系中,化学反应生成 5-氯-2-甲氧基苯甲酸
参考文献:A New Synthetic Route To Methoxytetralones
标题:A New Synthetic Route To Methoxytetralones
摘要:
DOI:10.1021/jo01093A037

专利信息

专利号:US-10005720-B2
优先权日:2013-04-05
标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same
发明人：SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L
权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL
摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.

专利号:US-9265773-B2
优先权日:2011-09-08
标题 :Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
发明人：MCCOMAS CASEY C; LIVERTON NIGEL J; HABERMANN JOERG; KOCH UWE; NARJES FRANK; LI PENG; PENG XUANJIA; SOLL RICHARD; WU HAO; PALANI ANANDAN; HE SHUWEN; DAI XING; LIU HONG; LAI ZHONG; LONDON CLARE; XIAO DONG; ZORN NICOLAS; NARGUND RAVI
权利人:MCCOMAS CASEY C; LIVERTON NIGEL J; HABERMANN JOERG; KOCH UWE; NARJES FRANK; LI PENG; PENG XUANJIA; SOLL RICHARD; WU HAO; PALANI ANANDAN; HE SHUWEN; DAI XING; LIU HONG; LAI ZHONG; LONDON CLARE; XIAO DONG; ZORN NICOLAS; NARGUND RAVI; MERCK SHARP & DOHME; MSD ITALIA SRL
摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

专利号:BR-PI1102271-A2
优先权日:2011-05-26
标 题:Process for the total synthesis of enantiomerically pure ochratoxin alfa and its application in the synthesis of ochratoxin a

专利号:US-2018370905-A1
优先权日:2013-04-05
标题:Compounds Useful for the Treatment of Metabolic Disorders and Synthesis of the Same

专利号:US-2016046560-A1
优先权日:2013-04-05
标题 :Compounds useful for the treatment of metabolic disorders and synthesis of the same

专利号:WO-2014165816-A1
优先权日:2013-04-05
标 题 :Compounds useful for the treatment of metabolic disorders and synthesis of the same